 |
7/25/2008
|
|
|
Cancer News on the Net® is dedicated to bringing patients and their
families the latest news and information on cancer diagnosis, treatment and
prevention. This service is offered for free as our gift to you. Hopefully,
you will find it helpful. The only thing we ask is that you let us know how
we can improve! Please read this disclaimer before entering the site.
|
| |
|
|
Lung Cancer: Radiofrequency Ablation (RFA) of Lung Tumors
RFA is a promising local therapy that has evolved rapidly in recent years for the treatment of primary and secondary cancers in the lung. The feasibility and safety profile in humans are well established. Complications following RFA are similar to those of CT-guided lung biopsies. However, sufficient long term results beyond 5 years are not yet available due to the relatively short time that this technology has been in use. Patients with smaller tumors (less than or equal to 3 cm) and fewer tumor nodules (less than or equal to 5 lesions) who are considered poor surgical candidates or who develop residual or recurrent disease despite maximal conventional therapy, and have tumors that are away from vital structures are the best candidates for RFA. Hence, RFA can be safely offered to patients who cannot undergo surgical resection. However the role of RFA in patients who are candidates for surgical resection is unproven, and there is no evidence on whether RFA is more or less effective that focused radiation (sterotactic body radiation therapy). Overall, RFA is a highly promising modality that may be used to our patients' advantage either as a solitary treatment or in combination with conventional therapy. [more]
|
| |
New Potential Target Identified in Chemo-Resistant Ovarian Cancer
The study, which examined 93 ovarian cancer samples of ranging stages, found that high levels of TG2 corresponded with significantly lower patient survival than those with low levels of TG2. [more]
UCLA researchers use engineered common cold virus to image early spread of prostate cancer
Using an engineered common cold virus, UCLA researchers delivered a genetic payload to prostate cancer cells that allowed them, using Positron Emission Tomography (PET), to locate the diseased cells [more]
Researchers identify promising cancer drug target in prostate tumors
BOSTON--Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" [more]
|
|
|
|
|
|
|
|
|
|
|
|
|
Team5 Corporation located in Manhattan (New York) is a Web Development company specializing in
large scale database driven web sites.
{www.team5.com}
|
|
|
|
|
Features travel related content. Including access to online reservations
for hotels, car rentals and airfare searches.
{www.sundaynews.com}
|
|
|
|
 |
|
|
